IP Library › Patent Application 12099459
Patent Application
App. No. 12/099,459

Genetically Engineered and Phenotyped Mice and Stem Cell Clones for Producing the Same

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/099,459
Filed
Apr 8, 2008
Art Unit
1632
USPC
800/18
Abstract

The current invention relates to genetically engineered mice, cells derived from those mice, and polynucleotides and polypeptides corresponding to genes affected by the engineered mutation. The invention also relates to antibodies raised in a mouse of the invention. The invention further provides methods for using the mice, cells, polynucleotides, polypeptides and antibodies of the invention.

Claims (2)

1 - 4 . (canceled)

7 . A transgenic mouse whose genome comprises a disruption of a gene comprising SEQ ID NO: 15 and wherein said disruption results in a phenotype that differs from that of a wild-type mouse.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →